Hsu JH - Search Results

1

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.

Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein AK. Gera JF, et al. Among authors: hsu jh. J Biol Chem. 2004 Jan 23;279(4):2737-46. doi: 10.1074/jbc.M309999200. Epub 2003 Oct 23. J Biol Chem. 2004. PMID: 14576155 Free article.

2

Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.

Shi Y, Hsu JH, Hu L, Gera J, Lichtenstein A. Shi Y, et al. Among authors: hsu jh. J Biol Chem. 2002 May 3;277(18):15712-20. doi: 10.1074/jbc.M200043200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872747 Free article.

3

Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

Shi Y, Gera J, Hu L, Hsu JH, Bookstein R, Li W, Lichtenstein A. Shi Y, et al. Among authors: hsu jh. Cancer Res. 2002 Sep 1;62(17):5027-34. Cancer Res. 2002. PMID: 12208757

4

Downstream effectors of oncogenic ras in multiple myeloma cells.

Hu L, Shi Y, Hsu JH, Gera J, Van Ness B, Lichtenstein A. Hu L, et al. Among authors: hsu jh. Blood. 2003 Apr 15;101(8):3126-35. doi: 10.1182/blood-2002-08-2640. Epub 2002 Dec 19. Blood. 2003. PMID: 12515720 Free article.

5

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses.

Hsu JH, Shi Y, Hu L, Fisher M, Franke TF, Lichtenstein A. Hsu JH, et al. Oncogene. 2002 Feb 21;21(9):1391-400. doi: 10.1038/sj.onc.1205194. Oncogene. 2002. PMID: 11857082

6

Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.

Shi Y, Gera J, Hsu JH, Van Ness B, Lichtenstein A. Shi Y, et al. Among authors: hsu jh. Mol Cancer Ther. 2003 Jun;2(6):563-72. Mol Cancer Ther. 2003. PMID: 12813136

7

Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.

Hsu JH, Shi Y, Frost P, Yan H, Hoang B, Sharma S, Gera J, Lichtenstein A. Hsu JH, et al. Oncogene. 2004 Apr 22;23(19):3368-75. doi: 10.1038/sj.onc.1207459. Oncogene. 2004. PMID: 15021914

8

The AKT kinase is activated in multiple myeloma tumor cells.

Hsu J, Shi Y, Krajewski S, Renner S, Fisher M, Reed JC, Franke TF, Lichtenstein A. Hsu J, et al. Blood. 2001 Nov 1;98(9):2853-5. doi: 10.1182/blood.v98.9.2853. Blood. 2001. PMID: 11675360 Free article.

9

Exendin-4, a glucagon-like peptide-1 receptor agonist, regulates ductus arteriosus by vasodilation and anti-remodeling through the PKA pathway.

Liu YC, Tseng YH, Wu YH, Tong L, Tsai SP, Huang SE, Wu BN, Lo SH, Chen IC, Dai ZK, Yeh JL, Hsu JH. Liu YC, et al. Among authors: hsu jh. Eur J Pharmacol. 2024 Dec 15;985:177106. doi: 10.1016/j.ejphar.2024.177106. Epub 2024 Nov 6. Eur J Pharmacol. 2024. PMID: 39515563

10

Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan.

Hsu JH, Huang P, Li CW, Bourne A, Strong C, Ku SW. Hsu JH, et al. Harm Reduct J. 2024 Oct 7;21(1):181. doi: 10.1186/s12954-024-01094-8. Harm Reduct J. 2024. PMID: 39375670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters